J Korean Diabetes.  2013 Dec;14(4):186-189. 10.4093/jkd.2013.14.4.186.

Diabetes Mellitus and Osteoporosis

• Kim KM

• KMID: 2173933
• DOI: http://doi.org/10.4093/jkd.2013.14.4.186

Abstract

Osteoporosis is a metabolic bone disease characterized by progressive decline in bone mass and bone quality, and increased risk of fracture. As a consequence, osteoporosis has become a serious health problem in aging societies. Diabetes, a chronic metabolic disorder with substantial morbidity and mortality, is also a major health problem and its prevalence is increasing rapidly. Recent meta-analyses and cohort studies have shown that type 1 and 2 diabetes are associated with higher fracture risk. These findings are partially explained by lower bone mineral density (BMD) in type I diabetes, and impaired bone quality might also cause fragility in diabetic bone. However, the mechanisms underlying low bone strength in type 1 and 2 diabetes are not fully understood. Strategies to improve BMD and to prevent osteoporotic fractures in patients with diabetes may include optimal glycemic control and aggressive prevention of complications. Moreover, increased awareness of osteoporosis is needed in view of the growing aging population of patients with diabetes mellitus.

Keyword

Osteoporosis; Bone fracture; Diabetes mellitus; Bone density

MeSH Terms

Aging
Bone Density
Bone Diseases, Metabolic
Cohort Studies
Diabetes Mellitus*
Fractures, Bone
Humans
Mortality
Osteoporosis*
Osteoporotic Fractures
Prevalence

Reference

References

1. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1–129.

2. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359:1761–7.

3. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999; 353:878–82.

4. Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008–2009. J Bone Miner Res. 2012; 27:1879–86.

5. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association. Park IeB, Kim J, Kim DJ, Chung CH, Oh JY, Park SW, Lee J, Choi KM, Min KW, Park JH, Son HS, Ahn CW, Kim H, Lee S, Lee IB, Choi I, Baik SH. Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabetes Metab J. 2013; 37:233–9.

6. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab. 1998; 11:413–9.

7. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by longterm poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res. 2002; 58:266–72.

8. Forst T, Pfützner A, Kann P, Schehler B, Lobmann R, Schäfer H, Andreas J, Bockisch A, Beyer J. Peripheral osteopenia in adult patients with insulindependent diabetes mellitus. Diabet Med. 1995; 12:874–9.

9. Kayath MJ, Dib SA, Vieira JG. Prevalence and magnitude of osteopenia associated with insulindependent diabetes mellitus. J Diabetes Complications. 1994; 8:97–104.

10. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care. 2008; 31:1729–35.

11. Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab. 2005; 289:E735–45.

12. Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care. 1996; 19:1388–92.

13. Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes. 2001; 109(Suppl 2):S493–514.

14. van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhäger JC, Pols HA. Bone density in non-insulindependent diabetes mellitus. The Rotterdam Study. Ann Intern Med. 1995; 122:409–14.

15. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB. Health ABC Study. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res. 2004; 19:1084–91.

16. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulindependent diabetes mellitus. JAMA. 1992; 268:3333–7.

17. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007; 166:495–505.

18. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a metaanalysis. Osteoporos Int. 2007; 18:427–44.

19. Nicodemus KK, Folsom AR. Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24:1192–7.

20. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006; 91:3404–10.

21. Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005; 48:1292–9.

22. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001; 14:525–8.

23. Liu Z, Aronson J, Wahl EC, Liu L, Perrien DS, Kern PA, Fowlkes JL, Thrailkill KM, Bunn RC, Cockrell GE, Skinner RA, Lumpkin CK Jr. A novel rat model for the study of deficits in bone formation in type-2 diabetes. Acta Orthop. 2007; 78:46–55.

24. Karagüzel G, Akçurin S, Ozdem S, Boz A, Bircan I. Bone mineral density and alterations of bone metabolism in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2006; 19:805–14.

25. Alexopoulou O, Jamart J, Devogelaer JP, Brichard S, de Nayer P, Buysschaert M. Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab. 2006; 32(5 Pt 1):453–8.

26. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes. 1995; 44:775–82.

27. Hie M, Iitsuka N, Otsuka T, Tsukamoto I. Insulindependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med. 2011; 28:455–62.

28. Hein G, Weiss C, Lehmann G, Niwa T, Stein G, Franke S. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis. 2006; 65:101–4.

29. Franke S, Siggelkow H, Wolf G, Hein G. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem. 2007; 113:154–61.